Skip to main content

Striking a Balance: Understanding Pain Management and Opioids

Omni Hotel
August 8, 2024
8:30 – 11 am ET
Louisville, KY

Presented by the American Academy of Hospice and Palliative Medicine, a member of the CO*RE Collaborative, nine interdisciplinary organizations working together to improve pain management and prevent adverse outcomes.

The CO*RE 2023-2024 curriculum, developed by nationally known experts in pain management, addiction, and opioids, thoughtfully balances the risks and benefits of opioid prescribing, providing the latest insights in this vital healthcare area. It covers many important topics, including understanding the nature and pathophysiology of pain, effective patient assessment, creating patient-centered pain treatment plans, non-pharmaceutical pain treatment options, managing patients on opioid analgesics, educating patients and caregivers, and addressing opioid use disorder.

This program meets many states’ requirements for opioid education and is fully compliant with the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) education requirement (“Blueprint”: FDA Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain | October 2023), issued by the U.S. Food & Drug Administration. As of June 27, 2023, DEA registrants are to have completed a total of at least 8 hours of training on opioid or other substance use disorders. This activity meets the criteria outlined by SAMHSA to count toward this training requirement.

Content is focused on the ability to make appropriate diagnostic and clinical decisions surrounding pain management and opioid use that have important consequences for patients and families experiencing serious and complex illnesses.

This course is planned for in-person attendance. The course will be recorded and planned to be released to registered attendees when available from the post-recording production team.

About the Course

Our didactic learning session is designed to provide a comprehensive and structured approach to pain management education. This course meticulously follows the FDA Blueprint, ensuring that participants receive the most up-to-date and evidence-based knowledge.

Desired Learning Outcomes

  • Describe the pathophysiology of pain as it relates to the concepts of pain management
  • Accurately assess patients in pain
  • Develop a safe and effective pain treatment plan
  • Identify evidence-based non-opioid options for the treatment of pain
  • Identify the risks and benefits of opioid therapy
  • Manage ongoing opioid therapy
  • Recognize behaviors that may be associated with opioid use disorder

Supplemental education also available includes modules on telehealth, addressing cannabis, fentanyl, stigma, and surgical education; a pocket-ready guide; a podcast series; and numerous brief teaching videos available through the CO*RE website.

Faculty

Kathleen Broglio, DNP ANP-BC ACHPN CARN-AP FPCN FAANP FAAHPM

Dr. Broglio is an Associate Professor of Medicine at Geisel School of Medicine at Dartmouth College, Nurse Practitioner in Palliative Medicine, Dartmouth Hitchcock Medical Center and Fellow of the American Academy of Hospice and Palliative Medicine.

Kathleen holds dual Board Certification in Hospice and Palliative Advanced Practice Nursing (ACHPN) and Certification in Addiction as a Certified Registered Nurse - Advance Practice (CARN-AP). She has conducted research on prevalence of opioid misuse risk in oncology; cannabis use in palliative medicine, and interprofessional palliative care education. Kathleen works with patients with serious illness, complex pain and symptom management needs and substance use disorders.

Dr. Broglio mentors colleagues, lectures and has published on the treatment of pain in the setting of risks for substance use disorder. Her experience includes acute and chronic pain management; and acute, ambulatory, and home-based palliative care.

Joseph W. Shega, MD

Dr. Shega is board certified in Geriatric and Hospice and Palliative Medicine and maintains an academic appointment at the University of Central Florida as an Associate Professor of Medicine. The first 15 years of his career was in academic medicine at Northwestern University and the University of Chicago doing clinical care, education, and research including NIH funding around serious illness and dementia care. For the past 10 years, Dr. Shega has practiced in Central Florida and serves as the chief medical officer for VITAS Healthcare.

In his current role, Dr. Shega has been instrumental in adapting a "mobile first" platform to bring technology to the bedside in patients homes to improve clinical care through enhanced clinical documentation, medication management, care coordination, and most recently virtual reality as an alternative treatment modality. Also, he has spearheaded efforts to integrate clinical research as a core pillar at VITAS. He has been appointed and serves on the National Academy of Medicine Roundtable on Quality Care for Persons with Serious Illness representing the American Geriatrics Society.

Dr. Shega is co-managing editor for the Essential Practices in Hospice and Palliative Medicine and has over 50 peer-reviewed publications focusing on the care of persons with serious illness. He works with medical trainees across the state of Florida including at the University of Central Florida, Veterans Administration, and HCA to create an ACGME accredited fellowship in Hospice and Palliative Medicine as well as faculty for the fellowship at Naples Community Hospital.

In 2024, Dr. Shega received the Josefina B. Mango Distinguished Hospice Physician Award from AAHPM due to his dedicated to the practice of palliative medicine in the hospice setting.

Registration

This course is open access at no charge to pre-registered attendees.

To register for this course, please call AAHPM Member Services at 847.375.4712. Member Services hours are available Monday-Friday, 8:30am – 5pm CT.

*PDF handouts which include the presentation slides and additional resources will be available for download to registered attendees.

Continuing Education Credits

The American Academy of Hospice and Palliative Medicine (AAHPM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

The AAHPM designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

In order to receive the designated 2.5 AMA PRA Category 1 Credits™ for this course, you must complete the online evaluation in your AAHPM LEARN account under your Pending Activities page. Learners must attend activity in its entirety, attest to attendance at time of evaluation completion, answer all post-test questions, score 70% or greater on the post-test. Once you pass the posttest, please complete the evaluation and claim your desired CE and certificate(s).

Evaluation period closes September 30, 2024, at 11:59pm CT for claiming CME credits.

Maintenance of Certification (MOC)

This activity is planned in the context of one or more of the ABMS/ACGME Competencies.

  • Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 MOC medical knowledge points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.5®. Please consult the ABA website, www.theABA.org for a list of all MOCA 2.0 requirements.
  • Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
  • Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 2.5 MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program.

Evaluation period closes September 30, 2024, at 11:59pm CT for claiming MOC credits.

Transfer Policy

If the course moves to a fully virtual meeting, registrants of the in-person meeting will automatically be transferred to the virtual meeting.

AAHPM reserves the right to substitute faculty, cancel or reschedule sessions for unforeseen circumstances. No refunds can be made for lodging, airfare, or any other expenses related to attending the summer course offerings.

Accommodations for Americans with Disabilities Act (ACT)

For potential participants in need of accommodation related to activity accessibility, please contact  This email address is being protected from spambots. You need JavaScript enabled to view it.  or call 847-375-4712 at least one month prior to the start of the conference activity.

Information on how to submit a request for accommodation will be provided upon inquiry. After the request is received, a phone call discussion will be initiated with the potential participant to determine the appropriate and necessary accommodations and resources needed.

Disclosure

The planners, faculty, and reviewers of this educational activity disclosed no relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is supported by an independent educational grant from the Opioid Analgesics REMS Program Companies (RPC). Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies.

This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration. For more information about the Opioid Analgesics REMS visit https://opioidanalgesicrems.com/RpcUI/products.u.

Disclaimer

The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a health care provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Any recommendations made by the authors and faculty of this activity must be weighed against the healthcare clinician’s own clinical judgment based on, but not limited to, such factors as the patient’s condition, benefits versus risks of suggested treatment, and comparison with recommendations of pharmaceutical compendia and other medical and palliative care authorities.

Please review AAHPM's educational events Code of Conduct.